Clinical Trial Update: GrafixPL PRIME Evaluation Case Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for GrafixPL PRIME evaluating outcomes in diabetic foot ulcers; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• GrafixPL PRIME

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Diabetic Foot Ulcer | Phase 4 | Status: COMPLETED | Results posted: 2020-07-30